CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.
September 12th 2023
Treatments intended to reduce biochemical recurrence in patients with prostate cancer may not improve long-term survival, recent research showed.
Lynparza Significantly Improves Survival in Subset of Patients with Metastatic Prostate Cancer
September 23rd 2020The PARP inhibitor Lynparza reduced the risk for death by 31% in men with metastatic castration-resistant prostate cancer compared with Xtandi or Zytiga plus the corticosteroid prednisone.